Nurse Practitioner, Adult Health · Hiawassee, GA
NPI
1235301946
Since 2008
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
103 Church St
Hiawassee, GA, 30546
Phone (706) 896-5858
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
3,489 services
Medicare patients, 2024
336
Average age 72
Drug cost, 2024
$972K
11,589 prescriptions
Company payments, 2025
$291
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Camille Y Ledford was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,320 times for 19 patients. In total Camille Y Ledford billed 3,489 services in 31 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,320 | 19 | $0.08 | $110 |
| 99214 Office E&M - Established | Office | 685 | 304 | $60.83 | $42K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 281 | 67 | $35.69 | $10K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 256 | 25 | $0.06 | $16.48 |
| 99497 Care Management/Coordination | Office | 200 | 200 | $65.71 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 176 | 176 | $102.75 | $18K |
| 96372 Injection Administration | Office | 145 | 40 | $7.61 | $1,103 |
| 99213 Office E&M - Established | Office | 112 | 87 | $48.36 | $5,416 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 78 | 33 | $29.43 | $2,295 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 71 | 11 | $0.88 | $62.53 |
| 81003 Clinical Chemistry | Office | 27 | 22 | $2.20 | $59.4 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 24 | 24 | $130.90 | $3,142 |
| 36415 Venipuncture Blood Collection | Office | 14 | 14 | $8.65 | $121 |
| 87811 Immunoassay | Office | 12 | 11 | $40.55 | $487 |
By year: 2022 $108K for 2,611 services; 2023 $89K for 1,893 services; 2024 $98K for 3,489 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 27 | 22 | $2.20 | $59.4 |
| 36415 Venipuncture Blood Collection | 14 | 14 | $8.65 | $121 |
| 87811 Immunoassay | 12 | 11 | $40.55 | $487 |
Medicare prescription drug claims, 2024
In 2024, the drug Camille Y Ledford prescribed most often to Medicare patients was Levothyroxine Sodium, with 546 prescriptions and refills. In total Camille Y Ledford wrote 11,589 Medicare prescriptions that cost $972K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 546 | 1,230 | 120 | $4,331 |
| Omeprazole Generic | 336 | 750 | 80 | $3,094 |
| Lisinopril Generic | 335 | 849 | 85 | $2,164 |
| Rosuvastatin Calcium Generic | 294 | 760 | 88 | $3,815 |
| Atorvastatin Calcium Generic | 224 | 569 | 61 | $1,688 |
| Tramadol Hcl Generic | 221 | 221 | 39 | $1,745 |
| Alprazolam Generic | 212 | 248 | 38 | $1,205 |
| Bupropion Xl Bupropion Hcl | 210 | 322 | 39 | $3,250 |
| Amlodipine Besylate Generic | 209 | 473 | 55 | $1,454 |
| Losartan Potassium Generic | 204 | 437 | 50 | $1,677 |
| Pantoprazole Sodium Generic | 187 | 411 | 44 | $1,931 |
| Fluoxetine Hcl Generic | 187 | 340 | 31 | $876 |
| Potassium Chloride Generic | 178 | 350 | 37 | $2,273 |
| Metoprolol Succinate Generic | 177 | 441 | 44 | $2,203 |
| Trazodone Hcl Generic | 171 | 335 | 39 | $998 |
Brand drugs: 1,436 claims; generic drugs: 10,076 claims; opioid claims: 252.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Camille Y Ledford $291 ($291 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $54.75.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $54.75 |
| Novo Nordisk Inc NVO | 3 | $52.02 |
| Lilly USA, LLC LLY | 2 | $35.61 |
| Exact Sciences Corporation EXAS | 2 | $34.19 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $23.74 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $19.67 |
| Amgen Inc. AMGN | 1 | $19.09 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $18.99 |
| Axsome Therapeutics, Inc. AXSM | 1 | $18.44 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $14.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.